Β-lactamases: Difference between revisions
From IDWiki
Β-lactamases
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
= Definition = |
== Definition == |
||
* Bacteria containing a plasmid that codes for an extended-spectrum beta-lactamase (ESBL) |
* Bacteria containing a plasmid that codes for an extended-spectrum beta-lactamase (ESBL) |
||
* Most common with ''Escherichia coli'' and ''Klebsiella'' |
* Most common with ''Escherichia coli'' and ''Klebsiella'' |
||
= Classification = |
== Classification == |
||
* Class A |
* Class A |
||
| Line 15: | Line 15: | ||
** Common in ''Citrobacter'', ''Serratia'', and ''Enterobacter'' |
** Common in ''Citrobacter'', ''Serratia'', and ''Enterobacter'' |
||
= Management = |
== Management == |
||
* Antibiotic therapy tailored to the resistance pattern |
* Antibiotic therapy tailored to the resistance pattern |
||
Revision as of 19:29, 15 August 2019
Definition
- Bacteria containing a plasmid that codes for an extended-spectrum beta-lactamase (ESBL)
- Most common with Escherichia coli and Klebsiella
Classification
- Class A
- Constitutively expressed plasmid
- Most common ESBL in Gram-negative bacteria
- Resistance to 2nd and 3rd generation cephalosporins
- Common in E. coli, Klebsiella, and Proteus spp.
- Class C
- Inducible AmpC gene present in the genome
- Common in Citrobacter, Serratia, and Enterobacter
Management
- Antibiotic therapy tailored to the resistance pattern
- Carbapenems, aminoglycosides, fluoroquinolones, and Septra typically work well
References
- ^ R. Cantón, M.I. Morosini, O. Martin, S. de la Maza, E. Gomez G. de la Pedrosa. IRT and CMT β-lactamases and inhibitor resistance. Clinical Microbiology and Infection. 2008;14:53-62. doi:10.1111/j.1469-0691.2007.01849.x.
